Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease

Journal of Diabetes Research
Claudia P OliveiraAline Marcadenti

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide and it is associated with other medical conditions such as diabetes mellitus, metabolic syndrome, and obesity. The mechanisms of the underlying disease development and progression are not completely established and there is no consensus concerning the pharmacological treatment. In the gold standard treatment for NAFLD weight loss, dietary therapy, and physical activity are included. However, little scientific evidence is available on diet and/or physical activity and NAFLD specifically. Many dietary approaches such as Mediterranean and DASH diet are used for treatment of other cardiometabolic risk factors such as insulin resistance and type-2 diabetes mellitus (T2DM), but on the basis of its components their role in NAFLD has been discussed. In this review, the implications of current dietary and exercise approaches, including Brazilian and other guidelines, are discussed, with a focus on determining the optimal nonpharmacological treatment to prescribe for NAFLD.

References

Apr 18, 1998·Gastroenterology·C P Day, O F James
Sep 14, 1999·The American Journal of Gastroenterology·E M BruntB R Bacon
Oct 31, 2002·Best Practice & Research. Clinical Gastroenterology·Wael I Youssef, Arthur J McCullough
Nov 6, 2002·Journal of Cellular and Molecular Medicine·Claudia P M S OliveiraA A Laudanna
Mar 26, 2003·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Bernard E Van BeersYves Horsmans
Dec 16, 2004·The Journal of Clinical Endocrinology and Metabolism·F AngelicoF Violi
Mar 3, 2005·The Journal of Clinical Endocrinology and Metabolism·Jukka WesterbackaHannele Yki-Järvinen
Sep 6, 2005·Journal of Hepatology·Ayako SuzukiPaul Angulo
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Geoffrey C Farrell, Claire Z Larter
May 2, 2006·Cellular and Molecular Life Sciences : CMLS·J-M Lavoie, M-S Gauthier
May 19, 2007·The American Journal of Gastroenterology·Ayako SuzukiKeith Lindor
May 19, 2007·The Journal of Clinical Investigation·Simon Schenk, Jeffrey F Horowitz
Aug 9, 2007·The American Journal of Clinical Nutrition·Angela M ZivkovicArun J Sanyal
Mar 6, 2008·American Journal of Physiology. Endocrinology and Metabolism·John J DubéBret H Goodpaster
Aug 8, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Alexander R Moschen, Herbert Tilg
Nov 11, 2008·Journal of Lipid Research·Cynthia A NagleRosalind A Coleman
Feb 19, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·S PettaA Craxì
Feb 27, 2009·Clinical Science·Christopher D ByrneMohamed H Ahmed
Mar 18, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luca MieleAntonio Grieco
May 16, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexis St GeorgeJacob George
Jul 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nathan A JohnsonJacob George
Oct 15, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kittichai PromratRena R Wing
Oct 28, 2009·Biochimica Et Biophysica Acta·Michael TraunerMartin Wagner
Dec 22, 2009·Nutrition·Maria Cristina EliasJoão Prola Netto
Mar 13, 2010·Journal of Biomedicine & Biotechnology·Claus Brandt, Bente K Pedersen
Apr 27, 2010·Alimentary Pharmacology & Therapeutics·G S MastertonP C Hayes
Apr 30, 2010·The New England Journal of Medicine·Arun J SanyalUNKNOWN NASH CRN
May 13, 2010·Digestive Diseases·Stefano BellentaniGiorgio Bedogni
Jun 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nathan A Johnson, Jacob George
Oct 21, 2010·Seminars in Liver Disease·Ariel E Feldstein
Feb 5, 2011·The Journal of Nutritional Biochemistry·Anna IaconoRosaria Meli
Jun 30, 2011·European Heart Journal·UNKNOWN European Association for Cardiovascular Prevention & RehabilitationUNKNOWN ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees
Sep 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kris V KowdleyUNKNOWN NASH Clinical Research Network
Jan 10, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Jill A ParnellRaylene A Reimer

❮ Previous
Next ❯

Citations

May 31, 2016·Metabolism: Clinical and Experimental·Niki KatsikiChristos S Mantzoros
Oct 23, 2016·Journal of Hepatology·Ryuki HashidaTakuji Torimura
Nov 22, 2016·Metabolic Syndrome and Related Disorders·Christina N KatsagoniMeropi D Kontogianni
Jun 1, 2017·The Nurse Practitioner·Jessica Wisocky, Sonali Paul
Mar 24, 2016·International Journal of Molecular Sciences·Stefano BallestriAmedeo Lonardo
Jan 24, 2017·Journal of Developmental Origins of Health and Disease·C LynchA J Drake
Apr 10, 2019·American Journal of Physiology. Endocrinology and Metabolism·Gaël EnnequinMartin Whitham
Dec 4, 2020·Journal of Gastroenterology and Hepatology·Shirin Hassani ZadehMahdieh Hosseinzadeh
Jul 31, 2021·American Journal of Preventive Cardiology·Harold E BaysPeter P Toth

❮ Previous
Next ❯

Software Mentioned

FibroScan
MeDiet

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.